2 August 2019
26 May 2019
READ MOREAkston Biosciences Begins Buildout of New GMP Biologics Manufacturing Facility
10 May 2019
READ MOREAkston Biosciences Completes Convertible Note Financing
17 May 2018
READ MOREAkston Biosciences Completes Series D Preferred Stock Financing
8 March 2023
READ MOREAkston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA
1 November 2022
READ MOREAkston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial
9 August 2022
READ MOREAkston Biosciences Receives U.S. Patent for Once-A-Week Human Insulin
24 June 2022
READ MOREBiolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine
12 May 2022
READ MOREAkston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster
12 April 2022